March 2, 2021
Sagicor Select Fund Manufacturing & Distribution (SELECTMD) for the year ended December 31, 2020 reported, dividend income of $68.55 million for the year and $13.51 million last year. Whereas other net changes in fair value amounted to a loss of $718.12 million for the year relative to an income of $187.05 million in 2019. Interest income closed the year at $1.92 million and relative to $220,000 last year. Other income amounted to $6.24 million (2019: nil) and Loss on sale of financial assets at fair value through profit or loss amounted to $8.31 million (2019: nil) for the year.
As such, total loss for the year under review equated $649.72 million relative to total income of $200.78 million the previous year. The total income for the quarter amounted to $238.83 million relative to total income of $166.45 million twelve months earlier.
Total expenses for the year closed at $27.87 million (2019: $40.23 million), while for the quarter, expenses amounted to $50.42 million (2019: $50.34 million).
Consequently, net loss closed the year at $677.59 million relative to a net profit of $160.54 million last year. Whereas the quarter net profit amounted to $233.51 million versus the net profit of $136.33 million booked last year.
Loss per share for the year under review amounted to $0.18 relative to an EPS of $0.04 in 2019, while for the quarter, SelectMD booked EPS of $0.06 versus an EPS of $0.04 in 2019. The number of shares used in this calculation was 3,816,612,000 shares. As at March 01, 2021 the stock traded at $0.76.
Balance Sheet Highlights:
Total assets, as at December 31, 2020, amounted to $3.28 billion (2019: $3.97 billion). Of this, Cash and Cash Equivalents booked $128.54 million (2019: $243.02 million), while Financial assets at fair value through profit or loss totalled $3.15 billion (2019: $3.72 billion).
Total equity as at December 31, 2020 amounted to $3.27 billion (2019: $3.94 billion), resulting in a net asset value per share of $0.86 (2019: $1.03).
Analyst Certification -The views expressed in this research report accurately reflect the personal views of Mayberry Investments Limited Research Department about those issuer (s) or securities as at the date of this report. Each research analyst (s) also certify that no part of their compensation was, is, or will be, directly or indirectly, related to the specific recommendation (s) or view (s) expressed by that research analyst in this research report.
Company Disclosure -The information contained herein has been obtained from sources believed to be reliable, however its accuracy and completeness cannot be guaranteed. You are hereby notified that any disclosure, copying, distribution or taking any action in reliance on the contents of this information is strictly prohibited and may be unlawful. Mayberry may effect transactions or have positions in securities mentioned herein. In addition, employees of Mayberry may have positions and effect transactions in the securities mentioned herein.